- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.09. | Lilly to Build $6.5B Manufacturing Facility in Houston, Texas | ||
| 23.09. | Arkivum and PHARMASEAL Partner to Streamline Clinical Trial Data Archiving | ||
| 23.09. | RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing | ||
| 23.09. | Eutecma Appoints Kevin Grogan as Chief Executive Officer | ||
| 23.09. | eXmoor, Siam Bioscience Partner to Establish CGT Services in Southeast Asia | ||
| 22.09. | Merck & Co.'s KEYTRUDA QLEX Approved by the FDA | ||
| 22.09. | Pharma Tech Industries Adds Industry Vet to Executive Team | ||
| 22.09. | Bristol Myers Squibb Commits to Veeva Vault CRM | ||
| 22.09. | Enzene Announces Commercial Supply of Pertuzumab | ||
| 22.09. | Evonik Launches MaxiPure Polysorbate 80 | ||
| 22.09. | Pfizer to Acquire Metsera Inc. for $4.9 Billion | ||
| 22.09. | Incyte Appointments Dave Gardner, EVP & Chief Strategy Officer | ||
| 22.09. | The Groninger Group Acquires Reinraumtechnik Ulm (RTU) | ||
| 18.09. | Roche to Acquire 89bio and Phase 3 MASH Candidate in Potential $3.5B Deal | ||
| 18.09. | Kindeva Opens New UK HQ and Manufacturing Site | ||
| 17.09. | Cellares Selects Technology Providers to Expand Cell Q's Capabilities | ||
| 17.09. | Wheeler Bio to Support MindImmune's Alzheimer's Prevention Program | ||
| 17.09. | Mabwell Bioscience, Aditum Bio Form Kalexo Bio | ||
| 17.09. | GSK to Invest $30B in R&D and Manufacturing in the U.S. | ||
| 16.09. | Lilly to Invest $5B in New Virginia Plant | ||
| 16.09. | Parexel Taps Rob Goodwin as COO | ||
| 16.09. | ProBioGen to Operate GMP Manufacturing Operation at Berlin Center for Gene & Cell Therapies | ||
| 16.09. | CSL Enters Strategic Collaboration with VarmX for VMX-C001 | ||
| 16.09. | Piramal Pharma Solutions Acquires Korsch XM-12 Bilayer Tablet Press | ||
| 16.09. | Carolina Molecular, Astoriom Partner to Provide Molecular Testing & Biospecimen Storage Services |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .